In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

Internationally, Dexcom has seen pockets of strength in key markets, such as Japan and France, where recent type 2 diabetes ...

DexCom, Inc. (DXCM), with a market cap of $33.9 billion, is a leading medical device company specializing in continuous ...

Medical device company DexCom (NASDAQ:DXCM) in Q1 CY2025, with sales up 12.5% year on year to $1.04 billion. The company ...